Epithalon

Epithalon (AEDG Peptide)

Also known as: Epitalon, AEDG

Low Risk

Anti-Aging

A synthetic tetrapeptide based on the pineal gland polypeptide Epithalamin. The flagship anti-aging peptide that activates telomerase to extend telomeres.

Benefits

Dose-dependent telomere extension via telomerase

May normalize melatonin production (bidirectional effect)

Extended lifespan in animal models

Enhanced thymus and immune function

Improved sleep and circadian rhythm

Antioxidant properties

Side Effects & Risks

Generally well toleratedmild

Injection site reactionsmild

Potential drowsinessmild

Dosing Information

Typical Dose

5-10 mg/day for 10-20 days

Administration

Subcutaneous injection

Cycle Length

10-20 day cycles, 2-3 times per year

Notes

Oral route ineffective. Short periodic cycles, not continuous.

Legal Status

FDA Status

Not FDA-approved

Availability

Research peptide suppliers

WADA Status

Not currently banned

Evidence

Evidence LevelLow

All published human data originates from a single research group (Khavinson, St. Petersburg). No independent Western replication. Telomere and melatonin claims lack independent verification. Promising preclinical concept but very limited evidence base.